
|Articles|August 15, 2006
Eliminate eye drops after routine phaco?
Intracameral triamcinolone may eliminate need for postop drops, pilot study finds
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Opus Genetics launches phase 1/2 MERTK gene therapy trial
3
Eye exams could enable earlier detection of systemic disease
4
FDA approves NDA labeling supplement allowing re-administration of iDose TR
5



























